Type 1 diabetes mellitus

• A phase 2b, single-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of oral Ladarixin in associa … Not authorised
  2025-524298-18-00 4 "new-onset autoimmune type 1 diabetes"
• IL-1β blockade to prevent Immunothrombosis in recipients of a Pancreatic Organ (ILIPO) Pending
  2025-524834-24-00 9 "diabetic patients pancreatic transplant"
• A first-in-human clinical trial using a gene therapy with patient’s own stem cells to treat early type 1 diabetes Recruiting
  2025-521304-21-00 7 2026-03-13 "Type 1 diabetes"
• LAMAinDiab - comparison of 2 pharmacological therapies (lisdexamphetamine vs methylphenidate) for pediatric patients with ADHD and type 1 di … Recruiting
  2023-506862-30-00 4 2024-11-24 "Attention-deficit hyperactivity disorder"
• Grafalon®therapy within 12 weeks of Type 1 diabetes (T1D) diagnosis in children and young adults to prevent the loss of residual beta cell f … Recruiting
  2023-508514-42-00 4 2024-06-04 "Type 1 diabetes"
• Frexalimab in preservation of endogenous insulin secretion compared to placebo in adults, adolescents and children on top of Insulin therapy … Recruiting
  2022-500531-36-00 4 2024-02-02
• An open-label extension multi-centre trial in adult subjects diagnosed with Type 1 diabetes mellitus exploring the effect of long-term Verap … Recruitment ended
  2024-515234-33-00 4 2024-11-21 "Type 1 diabetes mellitus (T1D)"
• Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes (REC1TE): a randomized, double-blind, placebo-controll … Recruitment ended
  2022-502038-23-00 4 2023-08-25 "Type 1 diabetes"
• A Trial to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Insulin GZR33 Compared with Insulin Degludec at stea … Ended
  2025-523052-32-00 3 2025-10-17 "Type 1 diabetes Mellitus"
• A randomised, double-blind, placebo controlled, parallel group, multi-centre trial in adult subjects with newly diagnosed type 1 diabetes me … Ended
  2023-506545-27-01 4 2025-01-28 "Diabetes mellitus, Type 1"
• A Study to evaluate the safety and feasibility of Diamyd® in individuals at risk for Type 1 diabetes Ended
  2024-513350-30-00 4 2024-07-09
• A study to learn how well the study treatment finerenone works and how safe it is in people with long-term decrease in the kidneys’ ability … Ended
  2022-503024-27-00 5 2024-02-27 "Chronic kidney disease associated with type 1 diabetes melli"
• A 12-month, randomized, single-blind, placebo-controlled exposure-response study of TCD601 (siplizumab) in new onset type 1 diabetes patient … Ended
  2023-506837-31-00 4 2023-01-27 "New onset type I diabetes"
• Evaluation of the effect of phenofibrate on the functions of beta cells in children with new diagnosis of type 1 diabetes Ended
  2024-517483-34-00 4 2022-09-21 "Evaluation of the effect of phenofibrate on the functions of"
• Study to evaluate the effect and the safety of ladaraxin in adult and adolescent patients with recent onset type 1 diabetes Ended
  2024-513560-26-00 4 2020-12-10 "Recent onset Type 1 Diabetes"

Showing 1–15 of 15 trials